[1]王志军,许祖闪,丛英珍,等.高场强MRI与X线钡餐造影、胃镜诊断胃癌术后复发的对比分析[J].国际放射医学核医学杂志,2012,36(1):46-52.[doi:10.3760/cma.j.issn.1673-4114.2012.01.012]
 WANG Zhi-jun,XU Zu-shan,CONG Ying-zhen,et al.The diagnosis of recurrent gastric carcinoma: high-field-strength MRI compared with barium meal of alimentary canal and gastroscope[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):46-52.[doi:10.3760/cma.j.issn.1673-4114.2012.01.012]
点击复制

高场强MRI与X线钡餐造影、胃镜诊断胃癌术后复发的对比分析(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
36
期数:
2012年第1期
页码:
46-52
栏目:
临床放射医学
出版日期:
2012-01-25

文章信息/Info

Title:
The diagnosis of recurrent gastric carcinoma: high-field-strength MRI compared with barium meal of alimentary canal and gastroscope
作者:
王志军 许祖闪 丛英珍 全勇 许东
264400 威海, 山东省威海市文登中心医院影像科
Author(s):
WANG Zhi-jun XU Zu-shan CONG Ying-zhen QUAN Yong XU Dong
Department of Imaging, the Wendeng Central Hospital of Weihai, Shandong Weihai 264400, China
关键词:
肖肿瘤肿瘤复发局部磁共振成像钡餐造影胃镜检查
Keywords:
Stomach neoplasmsNeoplasm recurrence localMagnetic resonance imagingBarium mealGastroscope
DOI:
10.3760/cma.j.issn.1673-4114.2012.01.012
摘要:
目的 通过高场强MRI与X线钡餐造影、胃镜检查的对比研究,探讨MRI在胃癌术后复发诊断中的应用价值。方法 收集临床拟诊胃癌术后复发患者53例,所有患者均接受MRI、X线钡餐造影、胃镜检查,以手术或穿刺活检病理结果为金标准,用卡方检验对上述检查方法进行统计分析。结果 53例胃癌术后患者经于术或穿刺活检病理证实:术后吻合口复发者30例,吻合口正常但发生周围及远处转移者10例,无复发者13例。MRI、X线钡餐造影和胃镜检查3种方法诊断胃癌术后吻合口复发的灵敏度、特异度、准确率、阳性预测值、阴性预测值分别为96.6%、86.9%、92.4%、90.6%、95.2%,70.0%、86.9%、77.3%、87.5%、68.9%,96.6%、91.3%、94.3%、93.5%、95.4%;诊断胃癌术后复发(包括胃外组织浸润、转移)的灵敏度、特异度、准确率、阳性预测值、阴性预测值分别为97.5%、76.9%、92.4%、92.8%、90.9%,52.5%、76.9%、58.4%、87.5%、34.4%,72.5%、84.6%、75.4%、93.5%、50.0%。诊断吻合口复发:MRI显著优于X线钡餐造影(χ2=4.90,P<0.05),MRI与胃镜检查结果比较,差异无统计学意义(χ2=0.03,P>0.05);诊断胃癌术后复发(包括胃外组织浸润、转移):MRI显著优于X线钡餐造影(χ2=12.46,P<0.05)和胃镜检查(χ2=5.26,P<0.05)。结论 在评价胃癌术后复发(包括胃外组织浸润、转移)中,MRI优于X线钡餐造影、胃镜检查;MRI对指导临床治疗方案,提高胃癌术后生存率具有重要的临床意义。
Abstract:
Objective To evaluate the clinical value of high-field-strength MRI in the diagnosis of recurrent gastric cancer compared with X-ray barium meal and gastroscope examinations.Methods All the 53 cases of postoperative recurrence of gastric cancer underwent MRI,X-ray barium meal and gastroscopy examinations.Using the results of surgery or biopsy as the gold standard,the differences in categorical data were analyzed with the Chi square test.Results Thirty postoperative recurrent gastric carcinoma in anastomotic stoma confirmed with pathological findings.There was ten cases with adjacent tissue infiltration and remote metastasis.Thirteen cases had no recurrent gastric carcinoma.The sensibility,specificity,accuracy,positive predictive value and negative predictive value for recurrent gastric carcinoma in anastomotic stoma for MRI,barium meal of alimentary canal and gastroscope were 96.6%,86.9%,92.4%,90.6%,95.2%; 70.0%,86.9%,77.3%,87.5%,68.9%; 96.6%,91.3%,94.3%,93.5%,95.4% respectively.The sensibility,specificity,accuracy,positive predictive value and negative predictive value for recurrent gastric cancer (including adjacent tissue infiltration and remote metastasis) were 97.5%,76.9%,92.4%,92.8%,90.9%; 52.5%,76.9%,58.4%,87.5%,34.4%; 72.5%,84.6%,75.4%,93.5%,50.0% respectively.There were significant differences between MRI and X-ray barium meal with respect to detect recurrent gastric carcinoma in anastomotic stoma and MRI is betterthan X-ray barium meal to detect recurrent gastriccarcinoma in anastomotic stoma (χ2=4.90,P<0.05).There were no significant differences between MRI and gastroscope with respect to detect recurrent gastric carcinoma in anastomotic stoma (χ2=0.03,P>0.05).In examination of recurrent gastric carcinoma including adjacent tissue infiltration and remote metastasis,MRI shows statistical differences with X-ray barium meal(χ2=12.46,P<0.05)and gastroscopy(χ2=5.26,P<0.05).Conclusions MRI had good diagnostic performance in identifying recurrent gastrie carcinoma,which is better than X-ray barium meal and gastroscope examinations.It plays an important role in directing clinical therapy and is helpful to improve postoperative survival rate of gastric carcinoma.

参考文献/References:

[1] 胡晔,陈炯.复发性胃癌56例的外科治疗.中国临床保健杂志,2005,8(6):516-517.
[2] Fleming ID, Cooper JS, Henson DE, et al. Stomach//American joint committee on cancer:AJCC cancer staging manual. 5th ed. Philadelphia:Lippineott-Raven, 1997:71-76.
[3] 郭健,李健丁.胃癌的影像诊断研究进展.中国医学影像技术,2003,19(7):936-938.
[4] 任刚,陈克敏.胃癌MRI检查的研究进展.中国临床医学影像杂志,2005,16(4):226-229.
[5] 冯元春,郭玉林,陈勇,等.进展期胃癌的多排螺旋CT和胃镜检查的对比研究.宁夏医学院学报,2007,29(6):580-582.
[6] Halpert RD, Feczko PJ. Role of radiology in the diagnosis and staging of gastric malignancy. Endoscopy, 1993, 25(1):39-45.
[7] 彭卫军,周康荣,秦新裕.CT在胃癌局部复发诊断中的应用评价.中国癌症杂志,2003,13(6):540-542.
[8] 程骏,温新东,黎金林,等.进展期胃癌术前磁共振成像的研究.温州医学院学报,2003,33(2):100-101.
[9] Kang BC, Kim JH, Kim KW, et al. Value of the dynamic and delayed MR sequence with Gd-DTPA in the T-staging of stomach cancer:correlation with the histopathology. Abdom Imaging, 2000, 25(1):14-24.
[10] 倪国汉.低场强MRI在胃癌诊断中的作用.放射学实践,2002,17(2):143-144.
[11] 彭卫军,周康荣,陈惠明.正常胃CT应用解剖和表现.临床放射学杂志,1997,16(6):352-355.
[12] 黄锐,孔祥泉.胃癌的MRI研究.放射学实践,2001,16(6):432-433.
[13] 谢德宁,商秀林.胃癌浸润转移的螺旋CT诊断.中国误诊学杂志,2006,6(6):1063-1064.

相似文献/References:

[1]李立芳,韩宝林.早期乳腺癌根治术后辅助放疗指征探讨[J].国际放射医学核医学杂志,2013,37(5):287.[doi:10.3760/cma.j.issn.1673-4114.2013.05.009]
 LI Li-fang,HAN Bao-lin.Indications for postmastectomy radiotherapy in early breast cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):287.[doi:10.3760/cma.j.issn.1673-4114.2013.05.009]
[2]李鹏,赵卫威,杨建伟.18F-FDG PET-CT在探测卵巢癌术后复发与转移中的应用价值[J].国际放射医学核医学杂志,2012,36(6):348.[doi:10.3760/cma.j.issn.1673-4114.2012.06.007]
 LI Peng,ZHAO Wei-wei,YANG Jian-wei.18F-FDG PET-CT imaging in the detection of recurrent and metastasis ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):348.[doi:10.3760/cma.j.issn.1673-4114.2012.06.007]
[3]梁吉祥,柴树德,郑广钧,等.CT引导下植入125I粒子治疗非小细胞肺癌切除术后局部复发的疗效[J].国际放射医学核医学杂志,2011,35(3):181.[doi:10.3760/cma.j.issn.1673-4114.2011.03.012]
 LIANG Ji-xiang,CHAI Shu-de,ZHENG Guang-jun,et al.CT-guided percutaneous interstitial implantation of 125I for recurrent patients of postoperative non-small cell lung carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):181.[doi:10.3760/cma.j.issn.1673-4114.2011.03.012]
[4]李生栩,唐明灯,林端瑜,等.18F-FDG SPECT-CT诊断胃癌术后复发及转移的价值[J].国际放射医学核医学杂志,2011,35(5):269.[doi:10.3760/cma.j.issn.1673-4114.2011.05.004]
 LI Sheng-xu,TANG Ming-deng,LIN Duan-yu,et al.The value of 18F-FDG SPECT-CT in detecting recurrence and metastasis of gastric carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):269.[doi:10.3760/cma.j.issn.1673-4114.2011.05.004]
[5]刘道佳,唐明灯,林端瑜,等.18F-FDG SPECT-CT在宫颈癌监测中的价值[J].国际放射医学核医学杂志,2010,34(3):155.
 LIU Dao-jia,TANG Ming-deng,LIN Duan-yu,et al.The value of 18F-FDG SPECT-CT in detecting recurrence or metastasis of cervical cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):155.
[6]王志军,丛英珍,许祖闪,等.高场强MRI在胃癌术后复发诊断中的应用价值[J].国际放射医学核医学杂志,2010,34(6):370.[doi:10.3760/cma.j.issn.1673-4114,2010.06.014]
 WANG Zhi-jun,CONG Ying-zhen,XU Zu-shan,et al.Application of high-field-strength magnetic resonance imaging to diagnose recurrent gastric carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):370.[doi:10.3760/cma.j.issn.1673-4114,2010.06.014]
[7]孙建鹰,杜明华.18F-氟脱氧葡萄糖显像在肺癌治疗中应用价值的[J].国际放射医学核医学杂志,2008,32(5):290.
 SUN Jian-yin,DU Ming-hua.The new advancement of application value of imaging techniques used 18F-fluorodeoxyglucose in therapy of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(1):290.
[8]邢岩,赵晋华.18F-氟脱氧葡萄糖PET及PET-CT早期诊断肿瘤复发[J].国际放射医学核医学杂志,2007,31(6):341.
 XING Yan,ZHAO Jin-hua.18F-fluorodeoxyglucose PET and PET-CT in early detection of cancer recurrent[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(1):341.
[9]袁卫红,李进,杨雷,等.125I粒子支架植入治疗结肠癌复发患者一例[J].国际放射医学核医学杂志,2007,31(4):255.
[10]陈艳芳,杨天恩,曹永珍.放射性脑损伤和脑肿瘤复发的鉴别诊断[J].国际放射医学核医学杂志,2006,30(5):308.
 CHEN Yah-fang,YANG Tian-en,CAO Yong-zhen.Differentiation between brain radiation injury and brain tumor recurrence[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(1):308.

备注/Memo

备注/Memo:
收稿日期:2011-10-25。
通讯作者:王志军,Email:zunkang001@sina.com
更新日期/Last Update: 1900-01-01